UK Biobank releases largest-ever genome sequencing dataset

After five years of painstaking lab work, more than 350,000 hours of genome sequencing and £200 million ($253 million) in investment, UK Biobank has completed and released

UK Biobank study “will shape drug discovery”

A landmark study drawing on data from UK Biobank has generated a first-of-its-kind dataset of the interactions between genes and proteins that could unlock myriad avenues

How data is crucial to the relaunch of the Cancer Moonshot

In this article, Ben Hargreaves takes a look at the renewed effort to tackle deaths from cancer in the US through the Cancer Moonshot.

Alnylam finds belly fat gene and drug target in UK Biobank s...

Alnylam Pharma has made a name for itself, developing gene-silencing therapies for rare disorders, but its latest discovery could take it into a much larger category – metabolic and cardiov

AI tool spots 59 possible COVID-19 drugs in UK Biobank data

Vifor joins forces with Evotec on kidney disease joint ventu...